Morgan Hunter
Investment Manager at BiomedVC
Pharma & Biotech
Dr. Morgan Hunter is an Investment Manager at BiomedVC, a Swiss venture capital firm investing in early-stage therapeutics across Europe.
Prior to joining Biomed in 2022, Morgan initiated and developed the business case for the planned ETH Zurich spin-off Emuna Therapeutics (CEO/CSO role), leading an Innosuisse Innovation Project and as an SNF BRIDGE Proof of Concept Fellow.
Morgan holds a Doctor of Sciences from ETH Zurich specializing in pharmaceutical immunology, vascular biology, and protein/antibody engineering; a Master of Science in Biochemistry from Rhodes University (South Africa); and a Financial Modelling and Valuation Analyst (FMVA)® certification from the Corporate Finance Institute (CFI).